nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2C18—Dapsone—malaria	0.0525	0.0676	CbGbCtD
Buprenorphine—CYP2C8—Sulfadiazine—malaria	0.0322	0.0415	CbGbCtD
Buprenorphine—CYP2C8—Pyrimethamine—malaria	0.0322	0.0415	CbGbCtD
Buprenorphine—CYP3A5—Artemether—malaria	0.0285	0.0367	CbGbCtD
Buprenorphine—CYP3A7—Quinine—malaria	0.023	0.0296	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Quinine—malaria	0.023	0.0296	CbGbCtD
Buprenorphine—CYP2C19—Artemether—malaria	0.023	0.0296	CbGbCtD
Buprenorphine—CYP3A4—Clindamycin—malaria	0.0227	0.0293	CbGbCtD
Buprenorphine—CYP2C9—Pyrimethamine—malaria	0.0225	0.0289	CbGbCtD
Buprenorphine—CYP2C9—Sulfadiazine—malaria	0.0225	0.0289	CbGbCtD
Buprenorphine—CYP2C19—Proguanil—malaria	0.0216	0.0278	CbGbCtD
Buprenorphine—CYP2D6—Pyrimethamine—malaria	0.0205	0.0264	CbGbCtD
Buprenorphine—CYP3A7—Quinidine—malaria	0.0202	0.026	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Quinidine—malaria	0.0202	0.026	CbGbCtD
Buprenorphine—CYP1A2—Proguanil—malaria	0.0199	0.0257	CbGbCtD
Buprenorphine—CYP2C9—Artemether—malaria	0.0191	0.0246	CbGbCtD
Buprenorphine—CYP2C9—Proguanil—malaria	0.018	0.0231	CbGbCtD
Buprenorphine—CYP2D6—Artemether—malaria	0.0175	0.0225	CbGbCtD
Buprenorphine—CYP3A7—Dapsone—malaria	0.0174	0.0224	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Dapsone—malaria	0.0174	0.0224	CbGbCtD
Buprenorphine—CYP3A5—Quinine—malaria	0.0173	0.0222	CbGbCtD
Buprenorphine—CYP2C8—Quinine—malaria	0.0166	0.0214	CbGbCtD
Buprenorphine—CYP2D6—Proguanil—malaria	0.0164	0.0211	CbGbCtD
Buprenorphine—CYP2D6—Quinidine barbiturate—malaria	0.0156	0.02	CbGbCtD
Buprenorphine—CYP2C8—Quinidine—malaria	0.0146	0.0188	CbGbCtD
Buprenorphine—CYP1A2—Pentoxifylline—malaria	0.0143	0.0184	CbGbCtD
Buprenorphine—CYP2C19—Quinine—malaria	0.0139	0.0179	CbGbCtD
Buprenorphine—CYP3A5—Dapsone—malaria	0.0131	0.0168	CbGbCtD
Buprenorphine—CYP3A4—Sulfadiazine—malaria	0.0131	0.0168	CbGbCtD
Buprenorphine—CYP1A2—Quinine—malaria	0.0128	0.0165	CbGbCtD
Buprenorphine—CYP2C8—Dapsone—malaria	0.0126	0.0162	CbGbCtD
Buprenorphine—CYP2C9—Quinine—malaria	0.0116	0.0149	CbGbCtD
Buprenorphine—CYP1A2—Quinidine—malaria	0.0113	0.0145	CbGbCtD
Buprenorphine—ABCB1—Quinine—malaria	0.0112	0.0145	CbGbCtD
Buprenorphine—CYP3A4—Artemether—malaria	0.0111	0.0143	CbGbCtD
Buprenorphine—CYP2D6—Quinine—malaria	0.0106	0.0136	CbGbCtD
Buprenorphine—CYP2C19—Dapsone—malaria	0.0105	0.0136	CbGbCtD
Buprenorphine—CYP3A4—Proguanil—malaria	0.0104	0.0134	CbGbCtD
Buprenorphine—CYP2C9—Quinidine—malaria	0.0102	0.0131	CbGbCtD
Buprenorphine—CYP3A4—Doxycycline—malaria	0.0099	0.0127	CbGbCtD
Buprenorphine—ABCB1—Quinidine—malaria	0.00987	0.0127	CbGbCtD
Buprenorphine—CYP2D6—Quinidine—malaria	0.0093	0.012	CbGbCtD
Buprenorphine—CYP2C9—Dapsone—malaria	0.00877	0.0113	CbGbCtD
Buprenorphine—CYP3A4—Quinine—malaria	0.00673	0.00866	CbGbCtD
Buprenorphine—CYP3A4—Quinidine—malaria	0.00591	0.00761	CbGbCtD
Buprenorphine—CYP3A4—Dapsone—malaria	0.0051	0.00657	CbGbCtD
Buprenorphine—OPRL1—hematopoietic system—malaria	0.00366	0.0686	CbGeAlD
Buprenorphine—Naloxone—TLR4—malaria	0.0034	1	CrCbGaD
Buprenorphine—OPRL1—blood—malaria	0.00243	0.0454	CbGeAlD
Buprenorphine—UGT1A9—kidney—malaria	0.00196	0.0366	CbGeAlD
Buprenorphine—UGT1A9—digestive system—malaria	0.00166	0.0311	CbGeAlD
Buprenorphine—CYP2C19—blood plasma—malaria	0.0016	0.03	CbGeAlD
Buprenorphine—OPRD1—kidney—malaria	0.00155	0.029	CbGeAlD
Buprenorphine—OPRL1—brain—malaria	0.00151	0.0282	CbGeAlD
Buprenorphine—CYP2C18—digestive system—malaria	0.00145	0.0272	CbGeAlD
Buprenorphine—CYP2C8—blood plasma—malaria	0.0014	0.0262	CbGeAlD
Buprenorphine—CYP1A2—blood plasma—malaria	0.00131	0.0245	CbGeAlD
Buprenorphine—OPRM1—hematopoietic system—malaria	0.00129	0.0241	CbGeAlD
Buprenorphine—CYP3A5—blood plasma—malaria	0.00126	0.0237	CbGeAlD
Buprenorphine—CYP2C9—blood plasma—malaria	0.00124	0.0233	CbGeAlD
Buprenorphine—UGT1A9—liver—malaria	0.00124	0.0232	CbGeAlD
Buprenorphine—CYP2C18—liver—malaria	0.00108	0.0202	CbGeAlD
Buprenorphine—CYP3A7—liver—malaria	0.00103	0.0193	CbGeAlD
Buprenorphine—CYP3A4—blood plasma—malaria	0.000948	0.0178	CbGeAlD
Buprenorphine—CYP2D6—blood plasma—malaria	0.000933	0.0175	CbGeAlD
Buprenorphine—CYP2C19—hematopoietic system—malaria	0.000887	0.0166	CbGeAlD
Buprenorphine—CYP3A7-CYP3A51P—liver—malaria	0.000874	0.0164	CbGeAlD
Buprenorphine—OPRM1—blood—malaria	0.000852	0.016	CbGeAlD
Buprenorphine—ABCG2—saliva-secreting gland—malaria	0.000789	0.0148	CbGeAlD
Buprenorphine—OPRD1—brain—malaria	0.000776	0.0145	CbGeAlD
Buprenorphine—CYP2C8—hematopoietic system—malaria	0.000774	0.0145	CbGeAlD
Buprenorphine—OPRK1—brain—malaria	0.000744	0.0139	CbGeAlD
Buprenorphine—CYP1A2—hematopoietic system—malaria	0.000724	0.0136	CbGeAlD
Buprenorphine—CYP2A6—liver—malaria	0.000714	0.0134	CbGeAlD
Buprenorphine—CYP3A5—hematopoietic system—malaria	0.000698	0.0131	CbGeAlD
Buprenorphine—CYP2C9—hematopoietic system—malaria	0.000687	0.0129	CbGeAlD
Buprenorphine—ABCB1—blood plasma—malaria	0.000671	0.0126	CbGeAlD
Buprenorphine—CYP2C8—kidney—malaria	0.000634	0.0119	CbGeAlD
Buprenorphine—CYP2C19—digestive system—malaria	0.000617	0.0116	CbGeAlD
Buprenorphine—CYP2C19—blood—malaria	0.000587	0.011	CbGeAlD
Buprenorphine—CYP3A5—kidney—malaria	0.000573	0.0107	CbGeAlD
Buprenorphine—CYP2A6—brain—malaria	0.000567	0.0106	CbGeAlD
Buprenorphine—OPRM1—brain—malaria	0.000529	0.00991	CbGeAlD
Buprenorphine—CYP3A4—hematopoietic system—malaria	0.000524	0.00982	CbGeAlD
Buprenorphine—CYP2D6—hematopoietic system—malaria	0.000516	0.00966	CbGeAlD
Buprenorphine—CYP2C8—blood—malaria	0.000513	0.0096	CbGeAlD
Buprenorphine—CYP1A2—digestive system—malaria	0.000504	0.00943	CbGeAlD
Buprenorphine—ABCG2—blood—malaria	0.000499	0.00934	CbGeAlD
Buprenorphine—CYP3A5—digestive system—malaria	0.000486	0.0091	CbGeAlD
Buprenorphine—ABCG2—bone marrow—malaria	0.000482	0.00904	CbGeAlD
Buprenorphine—CYP1A2—blood—malaria	0.00048	0.00899	CbGeAlD
Buprenorphine—CYP2C9—digestive system—malaria	0.000478	0.00896	CbGeAlD
Buprenorphine—CYP3A5—blood—malaria	0.000463	0.00867	CbGeAlD
Buprenorphine—CYP2C19—liver—malaria	0.000459	0.00861	CbGeAlD
Buprenorphine—CYP2C9—blood—malaria	0.000455	0.00853	CbGeAlD
Buprenorphine—CYP3A4—kidney—malaria	0.00043	0.00805	CbGeAlD
Buprenorphine—CYP2D6—kidney—malaria	0.000423	0.00792	CbGeAlD
Buprenorphine—CYP2C8—liver—malaria	0.000401	0.00751	CbGeAlD
Buprenorphine—ABCG2—liver—malaria	0.00039	0.0073	CbGeAlD
Buprenorphine—CYP1A2—liver—malaria	0.000375	0.00703	CbGeAlD
Buprenorphine—ABCB1—hematopoietic system—malaria	0.000371	0.00695	CbGeAlD
Buprenorphine—CYP3A4—digestive system—malaria	0.000365	0.00683	CbGeAlD
Buprenorphine—CYP3A5—liver—malaria	0.000362	0.00678	CbGeAlD
Buprenorphine—CYP2D6—digestive system—malaria	0.000359	0.00672	CbGeAlD
Buprenorphine—CYP2C9—liver—malaria	0.000356	0.00667	CbGeAlD
Buprenorphine—CYP3A4—blood—malaria	0.000347	0.00651	CbGeAlD
Buprenorphine—CYP2D6—blood—malaria	0.000342	0.0064	CbGeAlD
Buprenorphine—Erythema—Quinine—malaria	0.000332	0.002	CcSEcCtD
Buprenorphine—Malnutrition—Quinidine—malaria	0.000332	0.002	CcSEcCtD
Buprenorphine—Nausea—Proguanil—malaria	0.000332	0.002	CcSEcCtD
Buprenorphine—Visual impairment—Quinidine barbiturate—malaria	0.000332	0.002	CcSEcCtD
Buprenorphine—Dysgeusia—Clindamycin—malaria	0.000332	0.00199	CcSEcCtD
Buprenorphine—Vision blurred—Dapsone—malaria	0.00033	0.00198	CcSEcCtD
Buprenorphine—Back pain—Clindamycin—malaria	0.000328	0.00197	CcSEcCtD
Buprenorphine—Muscle spasms—Clindamycin—malaria	0.000326	0.00196	CcSEcCtD
Buprenorphine—Decreased appetite—Sulfadiazine—malaria	0.000323	0.00194	CcSEcCtD
Buprenorphine—Eye disorder—Quinidine barbiturate—malaria	0.000322	0.00194	CcSEcCtD
Buprenorphine—Tinnitus—Quinidine barbiturate—malaria	0.000321	0.00193	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Sulfadiazine—malaria	0.000321	0.00193	CcSEcCtD
Buprenorphine—Cardiac disorder—Quinidine barbiturate—malaria	0.00032	0.00192	CcSEcCtD
Buprenorphine—Flushing—Quinidine barbiturate—malaria	0.00032	0.00192	CcSEcCtD
Buprenorphine—Flushing—Pentoxifylline—malaria	0.000319	0.00192	CcSEcCtD
Buprenorphine—CYP2C8—brain—malaria	0.000318	0.00596	CbGeAlD
Buprenorphine—Vertigo—Dapsone—malaria	0.000315	0.00189	CcSEcCtD
Buprenorphine—Vision blurred—Quinine—malaria	0.000313	0.00188	CcSEcCtD
Buprenorphine—Vision blurred—Quinidine—malaria	0.000313	0.00188	CcSEcCtD
Buprenorphine—Tremor—Quinidine—malaria	0.000311	0.00187	CcSEcCtD
Buprenorphine—Tremor—Quinine—malaria	0.000311	0.00187	CcSEcCtD
Buprenorphine—Immune system disorder—Quinidine barbiturate—malaria	0.000311	0.00187	CcSEcCtD
Buprenorphine—Immune system disorder—Pentoxifylline—malaria	0.000311	0.00187	CcSEcCtD
Buprenorphine—Mediastinal disorder—Quinidine barbiturate—malaria	0.000311	0.00187	CcSEcCtD
Buprenorphine—ABCG2—brain—malaria	0.000309	0.00579	CbGeAlD
Buprenorphine—Chills—Quinidine barbiturate—malaria	0.000309	0.00186	CcSEcCtD
Buprenorphine—Cough—Dapsone—malaria	0.000306	0.00184	CcSEcCtD
Buprenorphine—Agitation—Quinidine—malaria	0.000305	0.00184	CcSEcCtD
Buprenorphine—Agitation—Quinine—malaria	0.000305	0.00184	CcSEcCtD
Buprenorphine—Vertigo—Clindamycin—malaria	0.000304	0.00183	CcSEcCtD
Buprenorphine—ABCB1—kidney—malaria	0.000304	0.0057	CbGeAlD
Buprenorphine—Angioedema—Quinine—malaria	0.000304	0.00183	CcSEcCtD
Buprenorphine—Angioedema—Quinidine—malaria	0.000304	0.00183	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Sulfadiazine—malaria	0.000304	0.00183	CcSEcCtD
Buprenorphine—Mental disorder—Quinidine barbiturate—malaria	0.000302	0.00181	CcSEcCtD
Buprenorphine—Erythema—Quinidine barbiturate—malaria	0.0003	0.0018	CcSEcCtD
Buprenorphine—Malnutrition—Quinidine barbiturate—malaria	0.0003	0.0018	CcSEcCtD
Buprenorphine—Erythema—Pentoxifylline—malaria	0.000299	0.0018	CcSEcCtD
Buprenorphine—Vertigo—Quinine—malaria	0.000299	0.00179	CcSEcCtD
Buprenorphine—Vertigo—Quinidine—malaria	0.000299	0.00179	CcSEcCtD
Buprenorphine—Syncope—Quinine—malaria	0.000298	0.00179	CcSEcCtD
Buprenorphine—Syncope—Quinidine—malaria	0.000298	0.00179	CcSEcCtD
Buprenorphine—Flatulence—Pentoxifylline—malaria	0.000295	0.00177	CcSEcCtD
Buprenorphine—Urticaria—Sulfadiazine—malaria	0.000295	0.00177	CcSEcCtD
Buprenorphine—Tension—Quinidine barbiturate—malaria	0.000294	0.00177	CcSEcCtD
Buprenorphine—Tension—Pentoxifylline—malaria	0.000294	0.00177	CcSEcCtD
Buprenorphine—Palpitations—Quinine—malaria	0.000294	0.00177	CcSEcCtD
Buprenorphine—Palpitations—Quinidine—malaria	0.000294	0.00177	CcSEcCtD
Buprenorphine—Abdominal pain—Sulfadiazine—malaria	0.000294	0.00176	CcSEcCtD
Buprenorphine—Body temperature increased—Sulfadiazine—malaria	0.000294	0.00176	CcSEcCtD
Buprenorphine—Dysgeusia—Pentoxifylline—malaria	0.000293	0.00176	CcSEcCtD
Buprenorphine—Hypertension—Clindamycin—malaria	0.000293	0.00176	CcSEcCtD
Buprenorphine—Loss of consciousness—Quinidine—malaria	0.000292	0.00176	CcSEcCtD
Buprenorphine—Loss of consciousness—Quinine—malaria	0.000292	0.00176	CcSEcCtD
Buprenorphine—Nervousness—Quinidine barbiturate—malaria	0.000291	0.00175	CcSEcCtD
Buprenorphine—Nervousness—Pentoxifylline—malaria	0.000291	0.00175	CcSEcCtD
Buprenorphine—Back pain—Pentoxifylline—malaria	0.00029	0.00174	CcSEcCtD
Buprenorphine—Convulsion—Quinidine—malaria	0.000288	0.00173	CcSEcCtD
Buprenorphine—Convulsion—Quinine—malaria	0.000288	0.00173	CcSEcCtD
Buprenorphine—Muscle spasms—Pentoxifylline—malaria	0.000288	0.00173	CcSEcCtD
Buprenorphine—Discomfort—Clindamycin—malaria	0.000285	0.00171	CcSEcCtD
Buprenorphine—Chest pain—Quinine—malaria	0.000283	0.0017	CcSEcCtD
Buprenorphine—Myalgia—Quinine—malaria	0.000283	0.0017	CcSEcCtD
Buprenorphine—Chest pain—Quinidine—malaria	0.000283	0.0017	CcSEcCtD
Buprenorphine—Myalgia—Quinidine—malaria	0.000283	0.0017	CcSEcCtD
Buprenorphine—Vision blurred—Quinidine barbiturate—malaria	0.000283	0.0017	CcSEcCtD
Buprenorphine—Vision blurred—Pentoxifylline—malaria	0.000282	0.0017	CcSEcCtD
Buprenorphine—Tremor—Quinidine barbiturate—malaria	0.000281	0.00169	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000281	0.00169	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000281	0.00169	CcSEcCtD
Buprenorphine—Tremor—Pentoxifylline—malaria	0.000281	0.00169	CcSEcCtD
Buprenorphine—Tachycardia—Dapsone—malaria	0.000279	0.00168	CcSEcCtD
Buprenorphine—Ill-defined disorder—Pentoxifylline—malaria	0.000278	0.00167	CcSEcCtD
Buprenorphine—Anaphylactic shock—Clindamycin—malaria	0.000277	0.00166	CcSEcCtD
Buprenorphine—Agitation—Quinidine barbiturate—malaria	0.000276	0.00166	CcSEcCtD
Buprenorphine—Agitation—Pentoxifylline—malaria	0.000275	0.00165	CcSEcCtD
Buprenorphine—Angioedema—Quinidine barbiturate—malaria	0.000274	0.00165	CcSEcCtD
Buprenorphine—Angioedema—Pentoxifylline—malaria	0.000274	0.00164	CcSEcCtD
Buprenorphine—Hypersensitivity—Sulfadiazine—malaria	0.000274	0.00164	CcSEcCtD
Buprenorphine—Confusional state—Quinine—malaria	0.000274	0.00164	CcSEcCtD
Buprenorphine—Confusional state—Quinidine—malaria	0.000274	0.00164	CcSEcCtD
Buprenorphine—CYP3A4—liver—malaria	0.000272	0.00509	CbGeAlD
Buprenorphine—Oedema—Quinidine—malaria	0.000271	0.00163	CcSEcCtD
Buprenorphine—Oedema—Quinine—malaria	0.000271	0.00163	CcSEcCtD
Buprenorphine—Malaise—Pentoxifylline—malaria	0.00027	0.00162	CcSEcCtD
Buprenorphine—Vertigo—Quinidine barbiturate—malaria	0.00027	0.00162	CcSEcCtD
Buprenorphine—Syncope—Quinidine barbiturate—malaria	0.000269	0.00162	CcSEcCtD
Buprenorphine—CYP2D6—liver—malaria	0.000267	0.00501	CbGeAlD
Buprenorphine—Shock—Quinidine—malaria	0.000267	0.0016	CcSEcCtD
Buprenorphine—Shock—Quinine—malaria	0.000267	0.0016	CcSEcCtD
Buprenorphine—Nervous system disorder—Quinidine—malaria	0.000266	0.0016	CcSEcCtD
Buprenorphine—Nervous system disorder—Quinine—malaria	0.000266	0.0016	CcSEcCtD
Buprenorphine—Palpitations—Quinidine barbiturate—malaria	0.000265	0.00159	CcSEcCtD
Buprenorphine—Tachycardia—Quinidine—malaria	0.000265	0.00159	CcSEcCtD
Buprenorphine—Tachycardia—Quinine—malaria	0.000265	0.00159	CcSEcCtD
Buprenorphine—Palpitations—Pentoxifylline—malaria	0.000265	0.00159	CcSEcCtD
Buprenorphine—Loss of consciousness—Quinidine barbiturate—malaria	0.000264	0.00158	CcSEcCtD
Buprenorphine—Skin disorder—Quinine—malaria	0.000263	0.00158	CcSEcCtD
Buprenorphine—Skin disorder—Quinidine—malaria	0.000263	0.00158	CcSEcCtD
Buprenorphine—Pruritus—Sulfadiazine—malaria	0.000263	0.00158	CcSEcCtD
Buprenorphine—Hyperhidrosis—Quinidine—malaria	0.000262	0.00158	CcSEcCtD
Buprenorphine—Hyperhidrosis—Quinine—malaria	0.000262	0.00158	CcSEcCtD
Buprenorphine—Convulsion—Quinidine barbiturate—malaria	0.00026	0.00156	CcSEcCtD
Buprenorphine—Convulsion—Pentoxifylline—malaria	0.000259	0.00156	CcSEcCtD
Buprenorphine—Anorexia—Quinidine—malaria	0.000259	0.00155	CcSEcCtD
Buprenorphine—Anorexia—Quinine—malaria	0.000259	0.00155	CcSEcCtD
Buprenorphine—Insomnia—Dapsone—malaria	0.000259	0.00155	CcSEcCtD
Buprenorphine—Hypertension—Pentoxifylline—malaria	0.000259	0.00155	CcSEcCtD
Buprenorphine—Hypotension—Clindamycin—malaria	0.000258	0.00155	CcSEcCtD
Buprenorphine—ABCB1—digestive system—malaria	0.000258	0.00483	CbGeAlD
Buprenorphine—Arthralgia—Quinidine barbiturate—malaria	0.000255	0.00154	CcSEcCtD
Buprenorphine—Chest pain—Quinidine barbiturate—malaria	0.000255	0.00154	CcSEcCtD
Buprenorphine—Myalgia—Quinidine barbiturate—malaria	0.000255	0.00154	CcSEcCtD
Buprenorphine—Chest pain—Pentoxifylline—malaria	0.000255	0.00153	CcSEcCtD
Buprenorphine—Myalgia—Pentoxifylline—malaria	0.000255	0.00153	CcSEcCtD
Buprenorphine—Anxiety—Quinidine barbiturate—malaria	0.000255	0.00153	CcSEcCtD
Buprenorphine—Diarrhoea—Sulfadiazine—malaria	0.000254	0.00153	CcSEcCtD
Buprenorphine—Anxiety—Pentoxifylline—malaria	0.000254	0.00153	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000254	0.00152	CcSEcCtD
Buprenorphine—Hypotension—Quinidine—malaria	0.000253	0.00152	CcSEcCtD
Buprenorphine—Hypotension—Quinine—malaria	0.000253	0.00152	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000253	0.00152	CcSEcCtD
Buprenorphine—Discomfort—Pentoxifylline—malaria	0.000252	0.00151	CcSEcCtD
Buprenorphine—Dry mouth—Pentoxifylline—malaria	0.000249	0.0015	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Quinidine—malaria	0.000247	0.00149	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Quinine—malaria	0.000247	0.00149	CcSEcCtD
Buprenorphine—Confusional state—Quinidine barbiturate—malaria	0.000247	0.00148	CcSEcCtD
Buprenorphine—Dyspnoea—Clindamycin—malaria	0.000247	0.00148	CcSEcCtD
Buprenorphine—Confusional state—Pentoxifylline—malaria	0.000246	0.00148	CcSEcCtD
Buprenorphine—ABCB1—blood—malaria	0.000246	0.0046	CbGeAlD
Buprenorphine—Oedema—Quinidine barbiturate—malaria	0.000245	0.00147	CcSEcCtD
Buprenorphine—Anaphylactic shock—Pentoxifylline—malaria	0.000244	0.00147	CcSEcCtD
Buprenorphine—Oedema—Pentoxifylline—malaria	0.000244	0.00147	CcSEcCtD
Buprenorphine—Dyspepsia—Clindamycin—malaria	0.000243	0.00146	CcSEcCtD
Buprenorphine—Infection—Pentoxifylline—malaria	0.000243	0.00146	CcSEcCtD
Buprenorphine—Dyspnoea—Quinidine—malaria	0.000242	0.00145	CcSEcCtD
Buprenorphine—Dyspnoea—Quinine—malaria	0.000242	0.00145	CcSEcCtD
Buprenorphine—Shock—Quinidine barbiturate—malaria	0.000241	0.00145	CcSEcCtD
Buprenorphine—Shock—Pentoxifylline—malaria	0.00024	0.00145	CcSEcCtD
Buprenorphine—Nervous system disorder—Quinidine barbiturate—malaria	0.00024	0.00144	CcSEcCtD
Buprenorphine—Tachycardia—Quinidine barbiturate—malaria	0.000239	0.00144	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Clindamycin—malaria	0.000239	0.00143	CcSEcCtD
Buprenorphine—Tachycardia—Pentoxifylline—malaria	0.000239	0.00143	CcSEcCtD
Buprenorphine—Fatigue—Clindamycin—malaria	0.000238	0.00143	CcSEcCtD
Buprenorphine—ABCB1—bone marrow—malaria	0.000238	0.00446	CbGeAlD
Buprenorphine—Skin disorder—Quinidine barbiturate—malaria	0.000238	0.00143	CcSEcCtD
Buprenorphine—Skin disorder—Pentoxifylline—malaria	0.000237	0.00143	CcSEcCtD
Buprenorphine—Hyperhidrosis—Quinidine barbiturate—malaria	0.000237	0.00142	CcSEcCtD
Buprenorphine—Constipation—Clindamycin—malaria	0.000236	0.00142	CcSEcCtD
Buprenorphine—Pain—Clindamycin—malaria	0.000236	0.00142	CcSEcCtD
Buprenorphine—Hyperhidrosis—Pentoxifylline—malaria	0.000236	0.00142	CcSEcCtD
Buprenorphine—Vomiting—Sulfadiazine—malaria	0.000236	0.00142	CcSEcCtD
Buprenorphine—Decreased appetite—Quinine—malaria	0.000236	0.00142	CcSEcCtD
Buprenorphine—Decreased appetite—Quinidine—malaria	0.000236	0.00142	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Quinidine—malaria	0.000234	0.00141	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Quinine—malaria	0.000234	0.00141	CcSEcCtD
Buprenorphine—Rash—Sulfadiazine—malaria	0.000234	0.00141	CcSEcCtD
Buprenorphine—Dermatitis—Sulfadiazine—malaria	0.000234	0.00141	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Dapsone—malaria	0.000234	0.00141	CcSEcCtD
Buprenorphine—Anorexia—Quinidine barbiturate—malaria	0.000233	0.0014	CcSEcCtD
Buprenorphine—Anorexia—Pentoxifylline—malaria	0.000233	0.0014	CcSEcCtD
Buprenorphine—Headache—Sulfadiazine—malaria	0.000233	0.0014	CcSEcCtD
Buprenorphine—Hypotension—Quinidine barbiturate—malaria	0.000229	0.00138	CcSEcCtD
Buprenorphine—Hypotension—Pentoxifylline—malaria	0.000228	0.00137	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Clindamycin—malaria	0.000226	0.00136	CcSEcCtD
Buprenorphine—Abdominal pain—Dapsone—malaria	0.000226	0.00136	CcSEcCtD
Buprenorphine—Body temperature increased—Dapsone—malaria	0.000226	0.00136	CcSEcCtD
Buprenorphine—Feeling abnormal—Quinine—malaria	0.000224	0.00134	CcSEcCtD
Buprenorphine—Feeling abnormal—Quinidine—malaria	0.000224	0.00134	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000223	0.00134	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000223	0.00134	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Quinidine—malaria	0.000222	0.00133	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Quinine—malaria	0.000222	0.00133	CcSEcCtD
Buprenorphine—Insomnia—Pentoxifylline—malaria	0.000221	0.00133	CcSEcCtD
Buprenorphine—Nausea—Sulfadiazine—malaria	0.000221	0.00133	CcSEcCtD
Buprenorphine—Urticaria—Clindamycin—malaria	0.00022	0.00132	CcSEcCtD
Buprenorphine—Abdominal pain—Clindamycin—malaria	0.000219	0.00131	CcSEcCtD
Buprenorphine—Body temperature increased—Clindamycin—malaria	0.000219	0.00131	CcSEcCtD
Buprenorphine—Dyspnoea—Quinidine barbiturate—malaria	0.000218	0.00131	CcSEcCtD
Buprenorphine—Dyspnoea—Pentoxifylline—malaria	0.000218	0.00131	CcSEcCtD
Buprenorphine—Somnolence—Quinidine barbiturate—malaria	0.000218	0.00131	CcSEcCtD
Buprenorphine—Somnolence—Pentoxifylline—malaria	0.000217	0.00131	CcSEcCtD
Buprenorphine—Urticaria—Quinidine—malaria	0.000216	0.0013	CcSEcCtD
Buprenorphine—Urticaria—Quinine—malaria	0.000216	0.0013	CcSEcCtD
Buprenorphine—Dyspepsia—Pentoxifylline—malaria	0.000215	0.00129	CcSEcCtD
Buprenorphine—Body temperature increased—Quinidine—malaria	0.000214	0.00129	CcSEcCtD
Buprenorphine—Abdominal pain—Quinine—malaria	0.000214	0.00129	CcSEcCtD
Buprenorphine—Abdominal pain—Quinidine—malaria	0.000214	0.00129	CcSEcCtD
Buprenorphine—Body temperature increased—Quinine—malaria	0.000214	0.00129	CcSEcCtD
Buprenorphine—Decreased appetite—Quinidine barbiturate—malaria	0.000213	0.00128	CcSEcCtD
Buprenorphine—Decreased appetite—Pentoxifylline—malaria	0.000212	0.00128	CcSEcCtD
Buprenorphine—CYP2D6—brain—malaria	0.000212	0.00397	CbGeAlD
Buprenorphine—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000211	0.00127	CcSEcCtD
Buprenorphine—Pain—Quinidine barbiturate—malaria	0.000209	0.00126	CcSEcCtD
Buprenorphine—Constipation—Quinidine barbiturate—malaria	0.000209	0.00126	CcSEcCtD
Buprenorphine—Constipation—Pentoxifylline—malaria	0.000209	0.00126	CcSEcCtD
Buprenorphine—Hypersensitivity—Clindamycin—malaria	0.000204	0.00122	CcSEcCtD
Buprenorphine—Feeling abnormal—Quinidine barbiturate—malaria	0.000202	0.00121	CcSEcCtD
Buprenorphine—Feeling abnormal—Pentoxifylline—malaria	0.000201	0.00121	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Quinidine barbiturate—malaria	0.0002	0.0012	CcSEcCtD
Buprenorphine—Hypersensitivity—Quinidine—malaria	0.0002	0.0012	CcSEcCtD
Buprenorphine—Hypersensitivity—Quinine—malaria	0.0002	0.0012	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Pentoxifylline—malaria	0.0002	0.0012	CcSEcCtD
Buprenorphine—Asthenia—Clindamycin—malaria	0.000198	0.00119	CcSEcCtD
Buprenorphine—Pruritus—Clindamycin—malaria	0.000196	0.00118	CcSEcCtD
Buprenorphine—Asthenia—Quinine—malaria	0.000195	0.00117	CcSEcCtD
Buprenorphine—Asthenia—Quinidine—malaria	0.000195	0.00117	CcSEcCtD
Buprenorphine—Urticaria—Quinidine barbiturate—malaria	0.000194	0.00117	CcSEcCtD
Buprenorphine—Urticaria—Pentoxifylline—malaria	0.000194	0.00117	CcSEcCtD
Buprenorphine—Body temperature increased—Quinidine barbiturate—malaria	0.000194	0.00116	CcSEcCtD
Buprenorphine—Abdominal pain—Quinidine barbiturate—malaria	0.000194	0.00116	CcSEcCtD
Buprenorphine—Abdominal pain—Pentoxifylline—malaria	0.000193	0.00116	CcSEcCtD
Buprenorphine—Body temperature increased—Pentoxifylline—malaria	0.000193	0.00116	CcSEcCtD
Buprenorphine—ABCB1—liver—malaria	0.000192	0.0036	CbGeAlD
Buprenorphine—Pruritus—Quinidine—malaria	0.000192	0.00115	CcSEcCtD
Buprenorphine—Pruritus—Quinine—malaria	0.000192	0.00115	CcSEcCtD
Buprenorphine—Diarrhoea—Clindamycin—malaria	0.000189	0.00114	CcSEcCtD
Buprenorphine—Diarrhoea—Quinidine—malaria	0.000186	0.00112	CcSEcCtD
Buprenorphine—Diarrhoea—Quinine—malaria	0.000186	0.00112	CcSEcCtD
Buprenorphine—Dizziness—Clindamycin—malaria	0.000183	0.0011	CcSEcCtD
Buprenorphine—Vomiting—Dapsone—malaria	0.000182	0.00109	CcSEcCtD
Buprenorphine—Hypersensitivity—Quinidine barbiturate—malaria	0.00018	0.00108	CcSEcCtD
Buprenorphine—Hypersensitivity—Pentoxifylline—malaria	0.00018	0.00108	CcSEcCtD
Buprenorphine—Dizziness—Quinine—malaria	0.000179	0.00108	CcSEcCtD
Buprenorphine—Dizziness—Quinidine—malaria	0.000179	0.00108	CcSEcCtD
Buprenorphine—Headache—Dapsone—malaria	0.000179	0.00108	CcSEcCtD
Buprenorphine—Vomiting—Clindamycin—malaria	0.000176	0.00106	CcSEcCtD
Buprenorphine—Asthenia—Quinidine barbiturate—malaria	0.000176	0.00106	CcSEcCtD
Buprenorphine—Asthenia—Pentoxifylline—malaria	0.000175	0.00105	CcSEcCtD
Buprenorphine—Rash—Clindamycin—malaria	0.000174	0.00105	CcSEcCtD
Buprenorphine—Dermatitis—Clindamycin—malaria	0.000174	0.00105	CcSEcCtD
Buprenorphine—Headache—Clindamycin—malaria	0.000173	0.00104	CcSEcCtD
Buprenorphine—Pruritus—Quinidine barbiturate—malaria	0.000173	0.00104	CcSEcCtD
Buprenorphine—Pruritus—Pentoxifylline—malaria	0.000173	0.00104	CcSEcCtD
Buprenorphine—Vomiting—Quinine—malaria	0.000172	0.00104	CcSEcCtD
Buprenorphine—Vomiting—Quinidine—malaria	0.000172	0.00104	CcSEcCtD
Buprenorphine—Rash—Quinine—malaria	0.000171	0.00103	CcSEcCtD
Buprenorphine—Rash—Quinidine—malaria	0.000171	0.00103	CcSEcCtD
Buprenorphine—Dermatitis—Quinidine—malaria	0.000171	0.00103	CcSEcCtD
Buprenorphine—Dermatitis—Quinine—malaria	0.000171	0.00103	CcSEcCtD
Buprenorphine—Headache—Quinidine—malaria	0.00017	0.00102	CcSEcCtD
Buprenorphine—Headache—Quinine—malaria	0.00017	0.00102	CcSEcCtD
Buprenorphine—Nausea—Dapsone—malaria	0.00017	0.00102	CcSEcCtD
Buprenorphine—Diarrhoea—Quinidine barbiturate—malaria	0.000168	0.00101	CcSEcCtD
Buprenorphine—Diarrhoea—Pentoxifylline—malaria	0.000167	0.00101	CcSEcCtD
Buprenorphine—Nausea—Clindamycin—malaria	0.000164	0.000987	CcSEcCtD
Buprenorphine—Dizziness—Quinidine barbiturate—malaria	0.000162	0.000973	CcSEcCtD
Buprenorphine—Dizziness—Pentoxifylline—malaria	0.000162	0.000971	CcSEcCtD
Buprenorphine—Nausea—Quinidine—malaria	0.000161	0.000969	CcSEcCtD
Buprenorphine—Nausea—Quinine—malaria	0.000161	0.000969	CcSEcCtD
Buprenorphine—Vomiting—Quinidine barbiturate—malaria	0.000156	0.000936	CcSEcCtD
Buprenorphine—Vomiting—Pentoxifylline—malaria	0.000155	0.000934	CcSEcCtD
Buprenorphine—Rash—Quinidine barbiturate—malaria	0.000154	0.000928	CcSEcCtD
Buprenorphine—Dermatitis—Quinidine barbiturate—malaria	0.000154	0.000927	CcSEcCtD
Buprenorphine—Rash—Pentoxifylline—malaria	0.000154	0.000926	CcSEcCtD
Buprenorphine—Dermatitis—Pentoxifylline—malaria	0.000154	0.000925	CcSEcCtD
Buprenorphine—Headache—Quinidine barbiturate—malaria	0.000153	0.000922	CcSEcCtD
Buprenorphine—Headache—Pentoxifylline—malaria	0.000153	0.00092	CcSEcCtD
Buprenorphine—ABCB1—brain—malaria	0.000153	0.00286	CbGeAlD
Buprenorphine—Nausea—Quinidine barbiturate—malaria	0.000145	0.000874	CcSEcCtD
Buprenorphine—Nausea—Pentoxifylline—malaria	0.000145	0.000873	CcSEcCtD
